Philip Herman
Corporate Officer/Principal chez REPARE THERAPEUTICS INC.
Fortune : 13 656 $ au 31/05/2024
Postes actifs de Philip Herman
Sociétés | Poste | Début | Fin |
---|---|---|---|
REPARE THERAPEUTICS INC. | Corporate Officer/Principal | 05/01/2022 | - |
Historique de carrière de Philip Herman
Anciens postes connus de Philip Herman
Sociétés | Poste | Début | Fin |
---|---|---|---|
Y-MABS THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2018 | 31/12/2021 |
VANDA PHARMACEUTICALS INC. | Sales & Marketing | - | - |
DYAX CORP. | Sales & Marketing | - | - |
Formation de Philip Herman
Kellogg School of Management | Masters Business Admin |
Baldwin Wallace University School of Business | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Canada | 2 |
Opérationnelle
Corporate Officer/Principal | 2 |
Sales & Marketing | 2 |
Masters Business Admin | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
VANDA PHARMACEUTICALS INC. | Health Technology |
Y-MABS THERAPEUTICS, INC. | Health Technology |
REPARE THERAPEUTICS INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Dyax Corp.
Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
- Bourse
- Insiders
- Philip Herman
- Expérience